Aligos TherapeuticsALGS
那斯達克 · USD
5.54
+0.04
(+0.73%)
收盤 10/03 03:56 (UTC+8)
10/03 03:56 (UTC+8)
Aligos TherapeuticsALGS
5.54
+0.04
(+0.73%)
財務數據
損益表
- 0.01
- 0.01
- 0.01
- 0.01
- 0.00
- 0.01
- 0.01
- 0.00
- 0.03
- 0.28
- -63.22
- 7.61
- 19.60
- -50.43
- -50.56
- 210.29
- -23.21
- -77.19
- 1574.56
- 881.55
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 27,778 | 2,830 | 169 | 741 | 965 | 311 | 629 | 1,269 | 1,061 | 986 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 27,778 | 2,830 | 169 | 741 | 965 | 311 | 629 | 1,269 | 1,061 | 986 |
營業費用 | 29,668 | 29,759 | 21,983 | 29,102 | 19,532 | 19,554 | 21,192 | 21,400 | - | 23,032 |
研發費用 | 24,050 | 23,352 | 17,038 | 23,937 | 13,976 | 14,502 | 16,031 | 16,774 | 21,098 | 16,366 |
推銷及管理費用 | 5,618 | 6,407 | 4,945 | 5,165 | 5,556 | 5,052 | 5,161 | 4,626 | 6,377 | 6,666 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -1,890 | -26,929 | -21,814 | -28,361 | -18,567 | -19,243 | -20,563 | -20,131 | -26,414 | -22,046 |
其他收入及費用 | 3,197 | 4,206 | 1,963 | -3,120 | 2,889 | 62,374 | -61,560 | 963 | 31,664 | - |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | 1,307 | -22,723 | -19,851 | -31,481 | -15,678 | 43,131 | -82,123 | -19,168 | 5,250 | -34,839 |
所得稅 | 2,811 | 317 | 30 | 56 | 185 | 43 | 27 | 91 | 189 | 24 |
稅後純益 | -1,504 | -23,040 | -19,881 | -31,537 | -15,863 | 43,088 | -82,150 | -19,259 | 5,061 | -34,863 |
基本每股稅後盈餘(元) | -0.14 | -2.21 | -1.91 | -3.04 | -1.53 | 5.12 | -13.08 | -3.07 | 0.03 | -0.22 |
稀釋每股稅後盈餘(元) | -0.15 | -2.21 | -2.01 | -3.34 | 5.01 | -2.11 | -13.10 | -3.07 | 0.03 | -0.22 |
基本平均股數(千股) | 10430.00 | 10402.00 | 10383.00 | 10369.00 | 10351.00 | 8408.00 | 6282.00 | 6272.00 | 156442.00 | 156152.00 |
稀釋平均股數(千股) | 10430.00 | 10402.00 | 10383.00 | 10369.00 | 10351.00 | 8709.00 | 6282.00 | 6272.00 | 156646.00 | 156152.00 |
還原基本每股稅後盈餘(元) | -0.14 | -2.21 | -1.91 | -3.04 | -1.53 | 5.12 | -13.08 | -3.07 | 0.81 | -5.58 |
還原稀釋每股稅後盈餘(元) | -0.15 | -2.21 | -2.01 | -3.34 | 5.01 | -2.11 | -13.10 | -3.07 | 0.81 | -5.58 |
還原基本平均股數(千股) | 10,430 | 10,402 | 10,383 | 10,369 | 10,351 | 8,408 | 6,282 | 6,272 | 6,257 | 6,246 |
還原稀釋平均股數(千股) | 10,430 | 10,402 | 10,383 | 10,369 | 10,351 | 8,709 | 6,282 | 6,272 | 6,265 | 6,246 |
EBITDA(千元) | 1,490 | -22,796 | -20,038 | -31,971 | -16,316 | 43,188 | -80,659 | -18,230 | 5,400 | -34,249 |